Mouse model of COVID-19 in pregnancy shows benefit of paxlovid treatment

A new mouse model of infection with the COVID-19-causing SARS-CoV-2 virus during pregnancy tracks closely the disease course doctors have observed in SARS-CoV-2-infected pregnant patients, and suggests that treatment with the antiviral Paxlovid provides protection for both mother and child. The new model is described in a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.